Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Korsana Biosciences, Inc. (KRSA) had Operating Cash Flow per Share of $-7.29 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.07M |
|
$-3.53M |
|
-- |
|
$2.07M |
|
$7.05M |
|
$-4.97M |
|
$1.45M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-4.97M |
|
$-4.97M |
|
0.45M |
|
0.45M |
|
$-7.77 |
|
$-7.77 |
|
| Balance Sheet Financials | |
$4.63M |
|
-- |
|
$5.35M |
|
$9.98M |
|
$0.90M |
|
-- |
|
-- |
|
$0.90M |
|
$9.09M |
|
$9.09M |
|
$9.09M |
|
0.55M |
|
| Cash Flow Statement Financials | |
$-3.31M |
|
$0.00M |
|
$3.32M |
|
$3.23M |
|
$3.24M |
|
$0.01M |
|
$0.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-239.78% |
|
-239.78% |
|
-239.78% |
|
-170.11% |
|
-170.11% |
|
$-3.31M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
2.07 |
|
175.99 |
|
-38.83% |
|
-38.83% |
|
-35.33% |
|
-38.83% |
|
$16.64 |
|
$-7.29 |
|
|
Operating Cash Flow per Share |
$-7.29 |